Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Sarama Announces Change of Auditor February 17, 2026 Surface Metals Inc Engages Danayi Capital Corp. to Provide Digital Marketing Services February 17, 2026 Silver Institute: Market Heading for Sixth Straight Deficit in 2026 February 17, 2026
Surface Metals Inc Engages Danayi Capital Corp. to Provide Digital Marketing Services February 17, 2026